Your search returned 770 results.

Results
	1.	Proprotein Convertase Subtilisin Kexin 9 (PCSK9) Inhibition: A Lipocrinologic Review. [electronic resource] by Kalra, Sanjay Producer: 20190816 In: The Journal of the Association of Physicians of India vol. 66 Availability: No items available. Save to lists Add to cart (remove)
	2.	Proprotein convertase subtilisin/kexin 9 inhibitors in reducing cardiovascular outcomes: a systematic review and meta-analysis. [electronic resource] by Du, Heyue Li, Xiaodan Su, Na Li, Ling Hao, Xiaoting Gao, Haihui Kwong, Joey Sum-Wing Vandvik, Per Olav Yang, Xueli Nemeth, Imola Mordi, Ify R Li, Qianrui Zhang, Longhao Rao, Li Lang, Chim C Li, Jianshu Tian, Haoming Li, Sheyu Producer: 20200605 In: Heart (British Cardiac Society) vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pleiotropic effects of proprotein convertase subtilisin/kexin type 9 inhibitors? [electronic resource] by Filippatos, Theodosios D Christopoulou, Eliza C Elisaf, Moses S Producer: 20190926 In: Current opinion in lipidology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	PCSK9 inhibition in patients with heart transplantation: A case series. [electronic resource] by Sandesara, Pratik B Dhindsa, Devinder Hirsh, Benjamin Jokhadar, Maan Cole, Robert T Sperling, Laurence S Producer: 20200708 In: Journal of clinical lipidology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	[New perspectives in the treatment of hypercholesterolaemia since the availability of PCSK9 inhibitors]. [electronic resource] by Pintó, X Sarasa, I Producer: 20200528 In: Hipertension y riesgo vascular vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Expert consensus on the rational clinical use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. [electronic resource] by Achimastos, Apostolos Alexandrides, Theodoros Alexopoulos, Dimitrios Athyros, Vasilios Bargiota, Alexandra Bilianou, Eleni Chrysochoou, Christina Drogari, Evridiki Elisaf, Moses Ganotakis, Emanouel Goudevenos, Ioannis Ioannidis, Ioannis Kolovou, Genovefa Kotsis, Vasilios Lekakis, Ioannis Liberopoulos, Evangelos Melidonis, Andreas Nikolaou, Vasilios Ntaios, George Papanas, Nikolaos Pappas, Stavros Pitsavos, Christos Rallidis, Loukianos Richter, Dimitrios Skoumas, Ioannis Tentolouris, Nicolaos Tousoulis, Dimitrios Tselepis, Alexandros Tsioufis, Konstantinos Tziakas, Dimitrios Tziomalos, Konstantinos Vardas, Panagiotis Vlachopoulos, Charalabos Vlahakos, Dimitrios Producer: 20170105 In: Hormones (Athens, Greece) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	[Therapeutic options in hyperlipidemia]. [electronic resource] by Berent, Robert Berent, Theresa Sinzinger, Helmut Producer: 20190621 In: Wiener medizinische Wochenschrift (1946) vol. 168 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	PCSK9 inhibitors in the current management of atherosclerosis. [electronic resource] by Whayne, Thomas F Producer: 20170418 In: Archivos de cardiologia de Mexico vol. 87 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	From the Editor: Using PCSK9 inhibitors in practice. [electronic resource] by Brown, William Virgil Producer: 20190114 In: Journal of clinical lipidology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	PCSK9 inhibition in high-risk patients. [electronic resource] by Zijlstra, Laurien E Mooijaart, Simon P Jukema, J Wouter Producer: 20201009 In: Aging vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Reducing cholesterol levels to decrease cardiovascular events: the role of new proprotein convertase subtilisin/kexin type 9 inhibitors. [electronic resource] by Alberto, Zambon Producer: 20180718 In: Journal of cardiovascular medicine (Hagerstown, Md.) vol. 18 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Improving prevention: risk scores, imaging, and PCSK9 inhibitors. [electronic resource] by Lüscher, Thomas F Producer: 20170104 In: European heart journal vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	What is the impact of the 2017 cochrane systematic review and meta-analysis that evaluated the use of PCSK9 inhibitors for lowering cardiovascular disease and mortality? [electronic resource] by Jalloh, Mohamed A Doroudgar, Shadi Ip, Eric J Producer: 20180531 In: Expert opinion on pharmacotherapy vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Recent advance in lipid management: Focus on PCSK9I (Proprotein Convertase Subtilisin/ Kexin 9 Inhibitors). [electronic resource] by Kalra, Sanjay Producer: 20180820 In: JPMA. The Journal of the Pakistan Medical Association vol. 66 Availability: No items available. Save to lists Add to cart (remove)
	15.	Proprotein Convertase Subtilisin Kexin 9 Inhibitors. [electronic resource] by Pirillo, Angela Catapano, Alberico Luigi Producer: 20180918 In: Cardiology clinics vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	Dyslipidaemia: Anti-PCSK9 vaccines to halt atherosclerosis. [electronic resource] by Ummarino, Dario Producer: 20190806 In: Nature reviews. Cardiology vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	The onward march of PCSK9 inhibition. [electronic resource] by Higgins, Catrin A Rees, Alan Producer: 20190627 In: Current opinion in lipidology vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	PCSK9 inhibitors in familial hypercholesterolemia: What is the evidence? [electronic resource] by Paquette, Martine Hegele, Robert A Baass, Alexis Producer: 20191007 In: Journal of clinical lipidology vol. 12 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	From the Editor: Preventing cardiovascular death. [electronic resource] by Brown, William Virgil Producer: 20190114 In: Journal of clinical lipidology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	[Consensus document of the Spanish Society of Arteriosclerosis on indications of inhibitors of PCSK9]. [electronic resource] by Masana, Luis Ascaso, Juan F Civeira, Fernando Pedro-Botet, Juan Valdivielso, Pedro Guijarro, Carlos Mostaza, José López Miranda, José Pintó, Xavier Producer: 20170529 In: Clinica e investigacion en arteriosclerosis : publicacion oficial de la Sociedad Espanola de Arteriosclerosis vol. 28 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
4
5
6
7
8
9
10
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 770 results.